Jerald Korn - Aug 12, 2022 Form 4 Insider Report for Epizyme, Inc. (EPZM)

Role: Chief Operating Officer
Signature: /s/ John Weidenbruch, attorney-in-fact
Stock symbol: EPZM
Transactions as of: Aug 12, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/16/2022, 06:55 PM
Previous filing: Apr 4, 2022

Jerald Korn is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is voluntarily filed to report that in connection with that certain Agreement and Plan of Merger, by and among the Issuer, Ipsen Pharma SAS and Hibernia Merger Sub, Inc., dated as of June 27, 2022, the Reporting Person is no longer subject to Section 16 reporting.